Kristen graduated magna cum laude from Loyola University School of Law and is admitted to the Illinois bar. She has been working with biopharma patents since she became a patent agent in 2012. She is highly skilled in classic biotech patent matters involving DNA, RNA, protein, peptide and antibody sequences. She has supported pre-litigation opinions for multiple clients and due diligence projects ranging from early stage startups to late stage publicly traded targets. She also interfaces with patent counsel around the world and has been involved in European opposition matters.